PRESS RELEASE published on 10/10/2024 at 07:00, 1 year 6 months ago Valneva organise une journée investisseurs aujourd’hui à New York Valneva organise une journée investisseurs à New York pour présenter ses activités vaccinales et stratégie de création de valeur. Des présentations sur leurs principaux projets de R&D seront diffusées en direct à 16h00 CET R&D Valneva Vaccins Journée Investisseurs Création De Valeur
PRESS RELEASE published on 10/10/2024 at 07:00, 1 year 6 months ago Valneva Hosts Investor Day in New York City Valneva SE is hosting an investor day in New York City to discuss key value drivers, including Lyme disease vaccine, commercial vaccines, and R&D pipeline. Hybrid event with webcast and Q&A sessions Investor Day Valneva SE Lyme Disease Vaccine R&D Pipeline Commercial Vaccines
BRIEF published on 10/04/2024 at 07:35, 1 year 7 months ago Valneva SE Announces Changes in Shares and Voting Rights Euronext Paris Voting Rights Shares Capital Increase Valneva SE
BRIEF published on 10/04/2024 at 07:35, 1 year 7 months ago Valneva SE annonce des changements dans son actionnariat et ses droits de vote Euronext Paris Actions Augmentation De Capital Droit De Vote Valneva SE
PRESS RELEASE published on 10/04/2024 at 07:30, 1 year 7 months ago Valneva SE - Declaration of shares and voting rights - September 30, 2024 Valneva declares changes in shares and voting rights, including a transfer into bearer form and a capital increase without preferential subscription rights Voting Rights Shares Capital Increase Transfer Valneva
PRESS RELEASE published on 10/04/2024 at 07:30, 1 year 7 months ago Valneva SE - Déclaration d’actions et de droits de vote - 30 septembre 2024 Valneva a publié une déclaration d'actions et de droits de vote pour le 30 septembre 2024, incluant une augmentation de capital et des changements dans les droits de vote Euronext Paris Déclaration Droits De Vote Augmentation De Capital Valneva
BRIEF published on 10/03/2024 at 07:05, 1 year 7 months ago Valneva organise une journée investisseurs à New York New York Investisseurs Valneva Vaccins Chikungunya
BRIEF published on 10/03/2024 at 07:05, 1 year 7 months ago Valneva to Hold Investor Day in New York New York Investors Valneva Vaccines Chikungunya
PRESS RELEASE published on 10/03/2024 at 07:00, 1 year 7 months ago Valneva organise une journée investisseurs à New York le 10 octobre 2024 Valneva organise une journée investisseurs à New York le 10 octobre 2024 pour présenter son portefeuille de vaccins contre des maladies infectieuses. Événement en présentiel et retransmis en direct Valneva Vaccins Journée Investisseurs Maladies Infectieuses NY
PRESS RELEASE published on 10/03/2024 at 07:00, 1 year 7 months ago Valneva to Host Investor Day in New York on Thursday, October 10, 2024 at 10:00 AM ET Valneva SE to host Investor Day at Lotte New York Palace Hotel on Thursday, October 10, 2024, focusing on R&D pipeline and revenue-generating vaccines Investor Day Valneva SE Vaccine R&D Pipeline Lotte New York Palace Hotel
Published on 05/08/2026 at 01:50, 57 minutes ago Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 2 hours 2 minutes ago Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 2 hours 47 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 3 hours 17 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 3 hours 32 minutes ago BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/07/2026 at 23:23, 3 hours 23 minutes ago H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 3 hours 33 minutes ago EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 4 hours 42 minutes ago Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 6 hours 4 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 8 hours 1 minute ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 19:15, 7 hours 32 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 7 hours 32 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 7 hours 41 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 7 hours 41 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 7 hours 47 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
